<img src="https://ml.globenewswire.com/Resource/Download/2f2493cf-d10e-408c-b660-c049c5fb17e8?size=2" nborder="0" align="left" hspace="5" vspace="5" title="stx-logo.png" alt="Starton Therapeutics Inc."/>PARAMUS, N.J., Sept. 09, 2026 <a href="https://www.globenewswire.com" target="_blank">(GLOBE NEWSWIRE)</a> -- <a href="https://www.globenewswire.com/Tracker?data=ZXz-mbUITzIau7oWrHuY4-NNJ_zpHpyicv4bSaXWgeh451y1vpy0AXhQgOTMwwnWeiS6k0bcrr2qSoJqEpeyIn9jPOrAX98OhBlsE4eOGGE=" rel="nofollow" target="_blank" title="Starton Therapeutics Inc">Starton Therapeutics Inc</a>. (“Starton”), a clinical-stage biotechnology company employing standard-of-care therapies with proprietary delivery technologies, announced today that Chief Medical Officer, Dr. Jamie Oliver, PharmD., will present at the 17th Annual World Bispecific Summit held September 15-17, 2026, in Boston, MA. Details for the event are as follows: 17th Annual World Bispecific Summit Location: The Westin Boston Seaport District, Boston, MA Presentation Title: Reengineering Lenalidomide Exposure in Multiple Myeloma (MM) Bispecific Therapy Date: Tuesday, September 15, 2026 Time: 2:30 PM ET To learn more about the event, please visit <a href="https://www.globenewswire.com/Tracker?data=lJ7qJfpzjtCWGviGtD9RDCsn_1rbwjh4F5mZF0H-l2fpwRIbbjlRVN1_4hb-vYLv4hyrSCcI08y6roc_2QMXF0g0A2uvm5WWsWWz82CCW5M=" rel="nofollow" target="_blank" title="">https://bispecific.com/</a>. About Starton Therapeutics Starton Therapeutics is a clinical-stage biotechnology platform company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer live better, for longer. Starton’s proprietary technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. To learn more, visit <a href="https://www.globenewswire.com/Tracker?data=cDBmed5D6WFPxUelIsGqJRWVVkGMIc23IfXlHqo4J3aFByKUMN5pQzNSbz5mbsvpGgDmf90kVYo-kcXNl9vu8Rehji51XXaGq-vTIXe9NEnbi-Z7tmtzl58Rcv0KdS-69fWUfm0ACR2ZE3DhpNztHNaluXtgxrTnz9_4WCq4s3lcMg90WNdVPATG5GH-gTBb98hEAyBGReoQxnnWXN6U_g==" rel="nofollow" target="_blank" title="www.startontx.com">www.startontx.com</a>. Forward Looking Statements All statements other than statements of historical facts included in this press release, including, without limitation, statements regarding our plans and objectives for future operations and expectations about current and future clinical trials, constitute “forward-looking statements.” Forward-looking statements are subject to numerous conditions and known and unknown risks and uncertainties that could cause our actual results or events to differ materially from those included within the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, and, except as required by law, Starton undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Media Relations Contact Greg Salsburg STiR Communications <a href="https://www.globenewswire.com/Tracker?data=J7dhRZo9SVAj0YUjFhKKdBqMP2S3NLqyY3G68U21f9nNLzYTFL85vrY_7WUJ8N0envU9eNbp6aN_YuKHD2MXtEBAD-8Q-cDGb9uPZ0NATEdce--bfms3zvXan7W779PP" rel="nofollow" target="_blank" title="Greg@STiR-communications.com">Greg@STiR-communications.com</a> Investor Relations Contact Eric Ribner Managing Director LifeSci Advisors <a href="https://www.globenewswire.com/Tracker?data=SEiIbnum3VgJuT-QTdRIhWB1f6H4cqvzYqb7GPfBo5XeVZ3vNU8BlJjqxQBZUYA8gF4iYdQ7gxcPCE80fDQ2eVIhPt819_dG0o3TPVlYTel-O4NZG0bsZiFiJYoTDYwz" rel="nofollow" target="_blank" title="eric@lifesciadvisors.com">eric@lifesciadvisors.com</a> <img alt="" src='https://ml.globenewswire.com/media/YTlhZDAwOGItNDI5MC00ZTQ3LWE2YTQtODgwZWYxM2EwNGU4LTUwMDEyNzM0MC0yMDI2LTA5LTA5LWVu/tiny/Starton-Therapeutics-Inc-.png' referrerpolicy='no-referrer-when-downgrade' />

Starton Therapeutics to Present at the 17th Annual World Bispecific Summit in Boston

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn